Connect with us

Health

EU’s Health Package is Europe’s answer to Trump’s drug pricing policy, says Várhelyi

SHARE:

Published

2 weeks ago

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

Várhelyi estimated reforms could lower business costs by 20-25 percent - potentially offsetting the impact of US tariffs and "MFN" pricing.

Asked about the impact of Trump’s so-called ‘most-favoured nation’ pricing, European Health Commissioner Olivér Várhelyi said that Europe’s strategy goes beyond pricing disputes and instead focuses on strengthening innovation, investment, and healthcare access across the EU.

Speaking after the Informal Health Council in Nicosia, Várhelyi stressed that the issue cannot be reduced solely to drug prices or tariffs and that recent regulatory decisions could reduce costs.

“My personal educated guess is that we are achieving between 20 and 25 percent cost reductions,” he said, suggesting that these savings could outweigh the impact of potential tariffs of around 15 percent.

The Commissioner said...

Advertisement

Share this article:

Share this:
Related Topics:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Advertisement

Trending